Shaolin Capital Management’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Shaolin Capital Management’s Portfolio AONC Stock Details AONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-100,000	Closed	-$1.03M	–	777
2023 Q2	$1.03M	Hold	100,000	–	–	0.03%	253
2023 Q1	$1.03M	Sell	100,000 -354,738	-78%	-$3.6M	0.03%	299
2022 Q4	$4.57M	Hold	454,738	–	–	0.14%	207
2022 Q3	$4.47M	Sell	454,738 -150,000	-25%	-$1.47M	0.12%	241
2022 Q2	$5.91M	Buy	+604,738	New	+$5.92M	0.14%	192

Other funds holding AONC

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Shaolin Capital Management's AONC Position: Q3 2023 in Review

Shaolin Capital Management sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q3 2023, closing a stake of 100,000 shares — an estimated $1.03M sold.

Shaolin Capital Management first reported a position in AONC in Q2 2022 and held it in 5 quarters. The position peaked at $5.91M in Q2 2022. 3 funds tracked by Wall St. Rank hold AONC as of Q3 2023.

Shaolin Capital Management reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Shaolin Capital Management sold 100,000 American Oncology Network, Inc. Class A Common Stock shares in Q3 2023, an estimated $1.03M.
Shaolin Capital Management first reported a position in American Oncology Network, Inc. Class A Common Stock in Q2 2022 and held it in 5 quarters.
Shaolin Capital Management's American Oncology Network, Inc. Class A Common Stock position peaked at $5.91M in Q2 2022.
3 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q3 2023.

Based on Shaolin Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.